跳至主要内容
临床试验/NCT00285623
NCT00285623已完成不适用

An Non-interventional, Prospective, Non-controlled Study of the Use of TachoSil in Supportive Treatment in Surgery for Improvement of Haemostasis Where Standard Techniques Are Insufficient.

Nycomed1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2005年12月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Nycomed
入组人数
3,000
试验地点
1

研究概览

简要总结

The purpose of this study is to collect information, after exposure to TachoSil ®, of all thromboembolic events, immunological events and drug interactions leading to thromboembolic events or major bleeding. In addition, pharmacoeconomic data will be collected.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All subjects, treated with TachoSil ® by the participating physicians, will be registered with a set of basic data from their already existing data (i.e. no additional diagnostic procedures will be performed).
  • Subjects who will provide their written informed consent to use existing data, allow direct access to data and data processing.

排除标准

  • 未提供

研究者

发起方
Nycomed
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验